This review highlights the intricate relationship between obesity, gut microbiota, and GLP-1 agonists, providing valuable insights into their combined role in effective obesity treatment and metabolic health enhancement. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.